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Enzyme-functionalized biological microfluidic (EF-BioMEMS) systems are an 
emerging class of lab-on-chip devices that manipulate enzymatic pathways by localizing 
reaction sites in a microfluidic network.  An EF-BioMEM system was fabricated to 
demonstrate biochemical enzyme inhibition.  Further, design optimizations to the EF-
BioMEM system have been proposed which improve system sensitivity and performance. 
The pfs enzyme is part of the quorum-sensing pathway that ultimately produces 
the bacterial signaling molecule AI-2.  An EF-BioMEM system was fabricated to 
investigate the pfs conversion activity in the presence of a transition state analogue 
inhibitor.  A reduction in enzyme conversion was measured in microfluidics for 
increasing inhibitor concentration that was comparable to the response expected on a 
larger scale.  This EF-BioMEMS testbed is capable of investigating other compounds that 
inhibit quorum sensing. 
Design improvements were demonstrates that improve overall system 
responsiveness by minimizing unintended reactions from non-specifically bound enzyme.  
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Chapter 1: Overview: Biological Enzyme-functionalized 
Microfludic Systems 
 
Enzyme-functionalized biological microfluidic systems (EF-BioMEMs) are an 
emerging class of lab-on-chip devices that manipulate enzymatic pathways by localizing 
reaction sites in a microfluidic network.  The motivation of this present work is to 
fabricate an EF-BioMEMS that is capable of screening enzyme inhibitor compounds, and 
investigating design optimizations that improve the signal-to-background performance of 
the system. 
The requirements of an EF-BioMEMS device are incorporation of active enzyme 
molecules, spatial localization of the enzyme on specific reaction sites, minimal 
contribution from non-specifically localized enzyme, and a method to introduce the 
reaction precursors and recover the reaction products.  Researchers at University of 
Maryland has previously employed chitosan as biological interconnect to spatially 
assemble active enzymes in microfluidic channels [38][39].  Chitosan is an amine-rich 
polysaccharide whose solubility is pH-responsive.  Its abundant amine groups allow for 
enzyme conjugation using tyrosine-tag based chemistry, while its pH responsiveness 
allows it to be electrodeposited on a cathode inside the microchannel. 
Section Chapter 2: (“An EF-BioMEM system to Investigate Enzyme Inhibition”) of 
this present work describes an EF-BioMEMs device that is capable of meeting these 
requirements, and in this present has been used to investigate the biochemical inhibition 
of an enzyme in the bacterial quorum-sensing pathway.  It will be shown that the enzyme 
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conversion activity decreased in a manner comparable to that observed in larger-scale 
well-mixed experimental configurations. 
Section Chapter 3: (“Design Optimizations for EF-BioMEMs”) of this thesis 
describes key design improvements to that reduce the unintended side reactions that 
degrade the system’s signal-to-background performance.  These unintended reactions 
take place in the homogenous phase (liquid), where active enzyme may become trapped 
in dead-volume sections of the device, or in the heterogeneous phase (on a surface), 
where active enzyme may be bound at locations other than the electrode reaction site.  
Modifications in the fabrication technique and the geometry of the device are explored, 
and shown to reduce the impact of these unintended side reactions on the overall system 
performance. 
 
Chapter 2: An EF-BioMEM system to Investigate Enzyme 
Inhibition  
Section 1 Introduction 
Microfluidic chips and polydimethylsiloxane (PDMS) soft lithography fabrication 
have reduced the size, reagent quantity, and cost of many standard biochemical analytical 
protocols, by handling nanoliter volumes [10][19].  Biological micro-electromechanical 
systems (bioMEMS) are an important subset of these devices that are able to recreate 
biomolecular reaction pathways.  Of particular interest are pathways that play a critical 
role in the functionality, and behavior of living cells.  Enzyme catalysis is central to many 
of these pathways, and accordingly it has been a major goal to develop means to isolate 
enzymes at specific locations in a microfluidic system, and confirm that their catalytic 
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action is maintained in this artificial setting.  This would provide an attractive testbed for 
understanding the details of reaction pathways and kinetics, and for identifying means to 
modify pathways (e.g., for discovery of a drug that can significantly suppress, enhance, 
or modify the dominant pathway). 
Our group has demonstrated bioMEMS technology that enables the programmable 
assembly of biomolecules on localized assembly sites in microchannels using 
electrodeposition of the amine-rich polysaccharide chitosan to direct the assembly 
[18][24][25].  Our group has recently demonstrated that a metabolic pathway enzyme, S-
adenosylhomocysteine nucleosidase (pfs), can be assembled in this way and that its 
catalytic action is retained in the microfluidic environment, shown by conversion of 
substrate S-adenosylhomocysteine (SAH) into products S-ribosylhomocysteine (SRH) 
and adenine, as illustrated in Figure 1(a)-(c) [39].  This reaction step is known to be one of 
two enzyme reaction steps by which bacteria produce autoinducer-2 (AI-2), a small cell-
signaling molecule that serves as a quorum-sensing communicator, through which 
bacterial populations exhibit altered phenotype (Figure 2).  Our ultimate goal is to use the 
EF-BioMEMs environment as a testbed for discovery of molecules that inhibit quorum 
sensing.  These compounds would be good candidates for a new type of antimicrobial 
drug that would work by interfering with bacterial communication, rather than by killing 
bacteria.  This strategy avoids generating drug-resistant mutations that are often the result 
of direct attack on the bacteria. 
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Figure 1: Parasitic reactions in microfluidics due 
to enzyme trapped in interconnect reservoirs and 
non-specifically bound on microchannel walls.  (a) 
pfs enzyme converts SAH substrate into products 
SRH and adenine.  (b) Electrical signal-guided 
assembly of pfs-chitosan conjugate onto a 
localized assembly electrode in a microchannel 
followed by buffer rinsing.  (c) Sequential 
enzymatic reaction in continuous flow in the 
microchannel.  (d) Parasitic reactions in reservoirs 
and on microchannel wall as well as 
programmable reactions on localized enzyme 
assembly site 
 
Figure 2: Quorum-sensing pathway to produce AI-2 signaling molecule [50] 
 
Section 2 Enzyme Inhibition 
AI-2 is a small signaling molecule that mediates interspecies bacterial cell–cell 
communication termed “quorum sensing”, a process in which an entire population of 
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bacteria coordinate their behavior in response to changes in their environment.  Quorum 
sensing is involved in regulating many of the genes associated with bacterial 
pathogenesis [1][26][39][28][30][31].  Inhibition or knockdown of enzymes in this pathway 
represents new opportunities for antimicrobial drugs that target population phenotype as 
opposed to essential biological functions. 
This strategy employs biochemical inhibitors to reduce the conversion activity of the 
pfs enzyme to inhibit the product of AI-2 precursors.  Enzymes are three-dimensional 
molecules that have active sites that are receptive to the particular molecular geometry of 
the substrate.  When the substrate docks in the active site, the enzyme rapidly undergoes 
a reversible conformal change which catalyses the conversion of the substrate into the 
product.  The product vacates the active site, and the enzyme reshapes ready for another 
substrate molecule.  Enzyme inhibition can proceed in a variety of ways, which fall into 
two classes: reversible and irreversible inhibition.  In reversible enzyme inhibition the 
inhibitor participates in a rapidly established, reversible equilibrium with the enzyme or 
enzyme-substrate complex.  This process can be modeled using Michaelis-Menten 
equations.  Irreversible inhibition occurs when the enzyme undergoes permanent 
modification to their active sites through covalent bonding, or the enzyme is decomposed.  
This type of inhibition cannot be modeled using Michaelis-Menten formalism, and is not 
the subject of this study [35]. 
The three types of reversible inhibition are: competitive inhibition, where the 
inhibitor competes with the substrate for access to the active site of the enzyme; 
uncompetitive inhibition, where the inhibitor binds to the enzyme-substrate complex to 
prevent product formation; and noncompetitive inhibition, where the inhibitor can bind to 
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both the free enzyme or the enzyme-substrate complex [35].  These types of reversible 
inhibition are shown in Table 1, where [E], [S], [I], [ES], [EI], [ESI] and [P] refer to the 
concentrations of enzyme, substrate, inhibitor, enzyme-substrate complex, enzyme-
inhibitor complex, enzyme-substrate-inhibitor complex, and product, respectively.  The 
key metric for an inhibitor is the dissociation constant of the inhibition reaction, KI, 
which is analogous to the binding affinity (i.e. smaller value means a stronger bond).  The 
dissociation constant for competitive inhibition is defined in Equation 1. 
 
Equation 1: Inhibitor dissociation constant 
 
The inhibitor discussed in this present work is a substrate analogue (i.e. a “lookalike”) 
that participates in competitive inhibition with the SAH substrate. 
Table 1: Types of reversible enzyme inhibition 
Uninhibited Reaction  
Competitive Inhibition  
Uncompetitive Inhibition  
Noncompetitive Inhibition  
 
Other researchers have investigated the integration of enzyme components into 
microfluidic devices.  Holden et al. have demonstrated site-specific enzyme patterning in 
microfluidic channels using photoimmobilization [41].  Ismagilov et al. have immobilized 
ß-galactosidase enzyme molecules in agarose gels formed within intersecting 
microfluidic channels [42], which they demonstrate to be catalytically active by 
introducing X-gal substrate.  Mao et al. have demonstrated phosphatase enzyme 
€ 
E + S⇔ ES⇔ E + P
! 
E + I + S" ES + I" ESI
! 
E + I + S" ES + I" ESI
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immobilization by streptavidin binding to a biotinilyated membrane in their microfluidic 
device.  They further demonstrate enzyme kinetics by varying substrate concentration to 
construct Lineweaver-Burke plots and extract the vmax and KM [43].  Fluorescence ELISA 
has been demonstrated by Eteshola and Leckband in microfluidics to be able to quantify 
the IgM sheep antibody down to nanomolar sensitivities [44].  Since ELISA depends 
critically upon enzyme immobilization to affix the complementary antigen, this study 
represented the replication of a common lab-bench procedure in an enzymatic 
microfluidics system. 
As stated, the strategy to prevent quorum sensing is to inhibit the enzymes involves 
in the synthesis of the signaling molecule, AI-2.  Of the two enzymes in the pathway, pfs 
and luxS, the luxS enzyme is less stable and not able to be readily electrodeposited within 
the microfluidic device, so the focus has been on inhibiting the pfs enzyme.  Despite this 
limitation for microfluidic assembly, a literature survey did uncover work by Alfaro et al. 
and Shen et al. that describe the synthesis of luxS substrate analogue inhibitors [50][51].  
Cornell et al. catalogs twenty-eight substrate analogues as potential inhibitors (in this 
study pfs is referred to as MTAN or 5’Methylthioadenosine nucleosidase), but not all the 
KI values are reported [52].  Of the values reported the dissociation constants ranged from 
20nM to 750nM. 
The most extensive work in the field of synthesizing pfs inhibitors has been done by 
Schramm et al.  Their research has identified listed several other picomolar and 
femtomolar pfs inhibitors [34][45][46][47][48], with exceedingly tight binding constants.  In a 
single paper, the team synthesized 51 subtly distinct substrate analogues by substituting 
key ligands on the SAH compound [34].  From this wide array, the tight-binding pfs (aka 
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MTAN) inhibitor called MT-DadMe-Immucillin-A (MT-DadMe) was selected (Figure 
3).  The name “MT-DadMe-Immucillin-A” refers to the location of the ligand 
substitution.  The full name is 5’-methylthio-DADMe-Immucillin-A (3R,4S)-1-[(9-
deazaadenin-9-yl)methyl]-3-hydroxy-4-(methylthiomethyl)pyrrolidine.  MT-DadMe was 
chosen primarily because it was a tight-binding inhibitor (equilibrium dissociation 
constant =2pM)1 and so would have a strong chance of producing measurable 
inhibition.  It was also the only compound that Dr. Schramm had available for shipping.  
MT-DadMe is a formally transition state analogue, which means it closely mimics the 
structure of the transition-state of the natural substrate, SAH, and can therefore achieve a 
very tight enzyme binding. 
  
 
(a) (b) (c) 
Figure 3: (a) MT-DadMe-Immucillin-A transition state analogue pfs inhibitor, 
(b) MTAN-catalyzed hydrolysis of MTA (aka SAH) and the dissociative transition state of the reaction 
Features of the transition state which distinguish it from the substrate are shown in blue, 
(c) SAH – MT-DadMe-Immucillin-A complex [48] 
 
 
                                                
1 In the case of slow-onset tight binding inhibition, such as this, the inhibitor-enzyme binding occurs in two phases.  In 
the first phase, the inhibitor binds reversibly to form the EI complex (Ki).  In the second phase, the EI complex 
undergoes a conformational tightening to bind the inhibitor even further (Ki*).  For MT-DadMe, the functional 
dissociation constant is given by Ki*.  
 9 
Section 3 Microfluidic Chip Design and Fabrication 
Sub-section 1 Design Objectives 
The chip was designed with nine (9) independent flow channels, and six electrodes 
per channel.  This allows five separate electrodeposition events to take place 
simultaneously within the same flow channel, while the sixth electrode is used repeatedly 
as the counter electrode.  The layout design of the electrode termini was inspired from 
DRAM chips, so that in the future it might be used as cartridges in a handheld control 
device.  The envisioned application is as a disposable testing cartridge capable of 
performing a variety of operations that involve enzyme reactions for in the roles of drug 
compound screening, small-scale manufacturing of short-lived signal products, or 
analyzing the interaction of an analyte with a fixed metabolic pathway.  The cartridges 
could be premade, and in a sealed ready state for enzyme functionalization and use. 







This bright-field mask allows for the patterning 
of two sets of 54 addressable, 1mm2 electrode 
pads.  Au/Cr electrodes are etched through 






This dark-field mask allows for the patterning of 
two sets of nine 0.5x18mm positive relief molds 
from UV-exposed SU8-50 negative photoresist.  
Microfluidic channels were cast in PDMS casts 
from these SU8-50 relief molds. 
Figure 4: Transparency Mask Set for (a) Electrodes, and (b) Microchannels 
 
Sub-section 2 Fabrication Procedure 
The microfluidic chip was built using soft lithographic techniques.  The microfluidic 
channels are designed to allow for the electrodeposition of enzyme-chitosan conjugate at 
specific locations, and then to allow for enzyme inhibition by flowing of inhibitor 
compounds.  The procedure is detailed in Table 2 below: 
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Table 2: Microfabrication of microfluidic chip 
Step Operation Approx. 
Time 
1 Transparency mask fabrication  
1-1 Dark field microchannel mask design using AutoCAD 
1-2 Bright field electrode mask design using AutoCAD 
2 days 
 Masks are printed on Mylar (transparency masks) by an external vendor (e.g. 
CAD/Art Services) 
3 days  
2 SU8 positive relief wafer formation  
2-1 Remove SU-8 50 from refrigerator at least 2 hours before process  
2-2 Clean the wafer with Acetone, Methanol, IPA cleaning and DI water rinsing, if 
not cleaned by piranha solution 
2 min 
2-3 Dehydrate the wafer on a hot plate (200°C, 30 min, auto-off) 30 min 
2-4 Prepare hotplates 65°C & 95°C 5 min 
2-5 Cover 2/3 of wafer surface (~4 ml) with SU-8 while wafer is on spinner 1 min 
2-6 Spin a 50 µm thick SU-8 50 film (100 rpm/sec ramp to 500 rpm, 10 sec; 300 
rpm/sec ramp to 2000 rpm, 30 sec) 
1 min 
2-7 Pre-bake SU-8 50 on 65°C hotplate, 6min then 95°C for 20 min 26 min 
2-8 Expose with 400 mJ/cm2 UV dose through Microchannel mask 15 min 
2-9 Post Exposure Bake SU-8 50 on 65°C hotplate for 1min ramp at 200°C/hr to 
95°C, hold at 95°C hotplate for 5 min, auto off 
30 min 
2-10 7min in SU-8 Developer, rinse briefly with IPA and gently dry with N2 10 min 
2-11 Hard bake the wafer at 150°C for 5 min, 300°C/hr, auto-off 30 min 
2-12 This produces the SU-8 positive relief wafer  
3 PDMS Processing  
3-1 Prepare 65°C oven  
3-2 Mix 10:1 ratio (prepolymer: curing agent) PDMS 10 min 
3-3 Pour PDMS over SU-8 positive relief wafer, degas under vacuum 25 min 
3-4 Cure in oven until solid 2 hrs 





4 Gold electrode fabrication  
4-1 Clean glass substrate slides in piranha solution right before evaporation    
4-2 Load glass substrate slides into thermal evaporator 10 min 
4-3 Thermally evaporate ~200Å of Chromium, as an adhesion layer between the 
gold and the glass 15 min 
4-4 Thermally evaporate ~2000Å of Gold, as the conductive layer 15 min 
4-5 Cover in Shipley 1813 photoresist, spun at 5000rpm, 30sec 1 min 
4-6 Soft bake (100°C, 1 min) 2 min 
4-7 Expose with 200 mJ/cm2 UV dose through Electrode mask 10 min 
4-8 Develop photoresist in Shipley 352 developer, and rinse 2-5 min 
4-9 Hard bake at 120°C for a few minutes 3 min 
4-10 Etch Gold layer in Transene TFA etchant, ~100sec 2 min 
4-11 Etch Chromium layer in Transene 1020 etchant, ~5-10sec 1 min 
4-12 Clean wafer with photoresist stripper (60°C, 5 min), then rinse in water 10 min 
4-13 This produces the gold electrodes on the glass substrates  
5 Final assembly  
5-1 Using razor blade and spatula, carefully peel off PDMS mold from SU-8 
positive relief wafer 
 
5-2 Holes are reverse-punched for the fluid tubing interface, using 0.75mm 
puncher 
5 min 
5-3 The PDMS layer and the gold-coated glass substrates are placed in the O2 
plasma asher 
 
5-4 Exposure to plasma: 450mTorr, 20W, 20sccm O2, 30 sec 5 min 
5-5 Immediately after removal from plasma, the two surfaces are placed in contact 
and a permanent bond is rapidly formed.  The bond sets overnight 
24 hrs 
5-6 Insert tubing into punched holes of the fluid channel (use 0.558mm ID/ 




Sub-section 3 Final Microfluidic Chip 








Figure 5: Microfluidic Chip 
(a) showing microchannel with incorporated gold electrodes, (b) photograph of microfluidic chip with 
multiple channels, electrode termini and inserted tubing, (c) shown with 50ml Falcon tube that was used for 
transportation and storage 
 
 
The final chip, as shown in Figure 5 (b) and (c), is compact, with nine (9) 
independent microfluidic channels with fifty-four (54) addressable electrode locations, 
supplied with fluid by nine (9) pairs of inlet-outlet tubing ports all on a single 1”x3” 
typical wafer slide.  The final chip was robust and could be easily stored on the shelf, or 
transported safely in common 50mL Falcon tube.  The terminus of each addressable 
electrode in the chip was designed to be easily accessed using Alligator clips and a 
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standard power control unit.  The batch fabrication techniques employed allowed many 
chips to be made in about 2 days of single-person labor using pre-designed mask sets.  
The materials choice and scale of manufacture with estimated cost of less than $10 per 
chip. 
Section 4 Experimental Methods 
The impact of the MT-DadMe inhibitor on pfs enzyme activity in the EF-BioMEM 
system was tested using the experimental design described below: 
 
1. Preparation 
a. The microfluidic chip was assembled with tubing and connected to a 
syringe pump. 
b. The channel was flushed with HCl at 10µL/min for at least 10min to 
remove any contaminants and denature any enzyme from a previous run. 
c. The channel was flushed with Milk blocking solution at 10µL/min for at 
least 2hrs to discourage non-specific chitosan bonding, and stabilize pH 
near the optimum value for enzyme catalysis. 
d. The channel was flushed with deionized (DI) water at 10µL/min for at 
least 30min to remove the Milk blocking solution. 
e. The pfs-chitosan tyrosine conjugate was brought to room temperature. 
2. Electrodeposition 
a. The microchannel was filled with pfs-chitosan tyrosine conjugate solution 
at 5µL/min for enough time to fill the microchannel. 
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b. An air bubble was introduced between the slug of conjugate solution, and 
the succeeding slug of PBS.  The air bubble was advanced to be just ahead 
of the depositing electrode so that the chitosan electrodeposition reaction 
can be rapidly terminated. 
c. The flow was stopped. 
d. Electrodeposition occurred by current control set to be 3A/m2 (1.5µA for 
an electrode area of 0.5mm2) by a Keithley 2600 SourceMeter for 4min.  
The depositing electrode was set as the cathode, and the counter electrode 
was set as the anode. 
e. Flow was restarted so that PBS flowed through the microchannel at 
5µL/min about 5 min. 
f. The tubing was changed to avoid cross-contamination. 
3. Enzyme Conversion 
a. The microchannel was flushed with 1mM SAH substrate at 4µL/min for 
1hr to prime the conversion.  The resulting product from this period was 
discarded. 
b. Batches of product were collected from SAH substrate flow (4µL/min) 
every 30min, for 1.5hr to yield three vials of 120µL each. 
c. Each sample vial was stored in a vat of ice to quench any lingering 
enzymatic conversions and prevent product denaturation. 
d. A sample of unconverted 1mM SAH solution was also collected as a 
standard. 
e. The tubing was changed to avoid cross-contamination. 
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4. Enzyme Inhibition 
a. 1mM SAH substrate and inhibitor solution were thoroughly mixed 
together to achieve the desired concentration.  The mixture was brought to 
room temperature. 







c. The microchannel was flushed with SAH-inhibitor solution at 4µL/min for 
1hr to prime the conversion.  The resulting product from this period was 
discarded. 
d. Batches of product were collected from SAH-inhibitor flow (4µL/min) 
every 30min, for 1.5hr to yield three vials of 120µL each. 
e. Each sample vial was stored in a vat of ice to quench any lingering 
enzymatic conversions and prevent product denaturation. 
f. The tubing was changed between experiments to avoid cross-
contamination. 




a. Samples were measured in HPLC. 
b. The SAH peak area was used as the metric to measure enzyme conversion. 
 
A few notes about the procedure: 
First, care was taken to always replace the tubing, as this is a major contributor to 
contamination.  Enzyme-chitosan conjugate or inhibitor can bind non-specifically to the 
interior walls of the tubing and interact with inhibitor to cause uncontrolled side 
reactions. 
Second, electrodes were only used once as deposition electrodes.  This was done so 
that each electrode was fresh for chitosan deposition and successive depositions were not 
complicated by previous actions.  This means that each channel was, at most, five times 
since there were six electrodes per channel, and one electrode was designated as the 
control terminal.  The microchannel was cleaned with HCl and buffer between each 
deposition and conversion process. 
Third, SAH was flowed for 1hr to prime the enzyme conversion because it had been 
observed that conversion products collected from the first 30-45minutes were erratic, 
with conversion rates varying by large amounts.  It appeared that after 1hr, the conversion 
rate stabilized and became more repeatable.  The schedule in Figure 7 was followed for 
sample collection. 
 
Section 5 Results 
High Performance Liquid Chromatography (HPLC) was used to determine the 
relative components of the product sample.  Different compounds have different elution 
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times based upon their affinity with the stationary phase of chromatography column.  In 
this case, the elution time for adenine is 4.8min, the elution time for SRH is 4.3 min, and 
the elution time for SAH is 8.4min [32].  By comparing the SAH peak area in a converted 
sample to that of the unconverted, it is possible to determine the amount of SAH 
remaining in the sample, and therefore the degree of enzymatic conversion.  The SRH 
peak was not used because it is of relatively low intensity compared to the SAH peak, 
and its elution time is too close to that of adenine to avoid being confused.  A typical 
HPLC elution plot is shown in Figure 6 below.  The y-axis measures the counts received 
by the absorbance detector, and it is common for this reading to have a baseline offset 
from zero (as shown in Figure 6), as this depends on the most recent zeroing of the 
detector.  This is easily accounted for by shifting the data to the correct zero line. 
 
Figure 6: Typical HPLC elution plot 
 
For each inhibitor concentration, the SAH peak area was plotted for the case with 
inhibitor mixed with substrate (Inh.), for the case of substrate alone (UnInh.), and for the 
associated inlet SAH concentration (Std.) in Figure 8.  The sample collection proceeded 
according to the following schedule in Figure 7.  This schedule includes a 1hr 
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stabilization period where SAH substrate and (if specified for that case) MT-DadMe 
inhibitor was introduced into the microchannel.  In preliminary tests, samples were 
collected during this 1hr period, but the data was highly erratic (not shown), so it was 
decided that the stabilization time should be employed. 
 
Figure 7: Sample collection schedule 
To compare all of these runs together and see how the impact of the inhibitor varies 
with concentration, it was necessary to use the Equation 2 below to determine the degree 
of enzyme conversion: 
 
Equation 2: Enzyme conversion computation 
 
Recalling that SAH is the substrate of the pfs enzyme reaction, it follows that a larger 
value of the SAH peak area in the sample implies a lower degree of enzymatic 
conversion.  This explains the inverse nature of the formula. 
Since it was observed that the SAH content of the substrate varied from batch to 
batch, as evidenced by the differing values of the std. SAH peak area as measured by 
HPLC, the standard SAH peak area refers to the mean value of the peak area of the 
unconverted SAH substrate from all batches.  This data is shown in Figure 9.  Clearly, the 
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Figure 8: SAH peak area for each inhibitor concentration.  Each colored bar represents a sample collection 





Figure 9: Microfluidic enzyme conversion in the presence of inhibitor 
 
To address the concerns of repeatability and crosstalk between individual tests, 
several precautions were taken.  First, the microfluidic chip design allowed each 
microchannel to have six individually addressable electrodes.  One electrode was 
designated the common counter electrode (anode), with the remaining five electrodes as 
single-use cathodes (electrodepositing).  Since the electrode was used only once for each 
test, it reduced the crosstalk that could occur by repeated depositions.  Second, the 
microchannel was flushed with HCl acid after and before each test to fully dissolve and 
rinse any remaining chitosan, and deactivate and eliminate any residual enzyme.  Third, 
the fluidic tubing was replaced fresh for each test to reduce the impact of non-specific 
binding.  Additionally, these tests at different inhibitor concentrations were conducted 
over a span of several weeks, while the device was stored on the shelf and the 
biochemical fluids were stored in the refrigerator. 
 
 22 
Section 6 Discussion 
Sub-section 1 “CSTR”-like calculations 
Lewandowski reports that the Michaelis-Menten, Km, constant for pfs enzyme to be 
Km=0.12±0.04mM and the maximum reaction rate for this enzyme conversion to be 
vmax=0.11±0.02mM/hr [33].  These values were determined using a different experimental 
design, as shown in Figure 10.  However, the pfs-chitosan conjugate used by Lewandoski 
was prepared in the same way as the current experiment, by the same personnel. 
 
 
Figure 10: Chitosan electrodeposition and pfs-chitosan conjugation, Lewandowski experimental setup [33] 
 
For this particular inhibitor, MT-DadMe-Immucillin-A & enzyme, Schramm et al. 
reports that the inhibition constant be KI=2x10-9mM, and the Michaelis-Menten constant 
to be KM=4.3x10-3mM [34].  This value was determined by ultraviolet absorption using the 
extinction coefficients of the reaction products in volumes of 1mL at 25°C.  Using pfs-
chitosan conjugate deposited on large-scale chips, Lewandowski reports that the 
Michaelis-Menten, KM, constant for pfs enzyme to be KM=1.2x10-1mM, and the 
maximum reaction rate for this enzyme conversion to be vmax=0.11±0.02mM/hr [33].  Both 
of these values for KM are relatively close to each other, suggesting that while chitosan 
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immobilization does affect the equilibrium conditions, it is not such a strong effect to 
negate entirely the ability of the pfs enzyme to perform substrate conversion. 
Since both of these referenced experimental arrangements more closely approximate 
a well-mixed, continuously-stirred reactor design than the microfluidic channel 
arrangement of the current study, the values given here represent an upper bound on the 
kinetics of reaction kinetics for this system.  Ideally, a continuously stirred reaction 
design allows for all the species in the solution (i.e. enzyme, inhibitor and enzyme) to 
interact freely. 
The type of enzyme inhibition that is occurring is competitive inhibition of the 
substrate (SAH) for the active enzyme (pfs) sites by a tight-binding substrate transition-
state analog (MT-DadMe).  This inhibitor binds to the enzyme, preventing it from 
effecting substrate catalysis.  Since the binding of the analog is so strong, many substrate 
molecules flow by in the fluid stream unconverted. 
This competitive inhibition may be described by two competing reaction pathways: 
 
Equation 3: Competing Reaction Pathways 
 
Using the formula, shown in Equation 4, for competitive inhibition it is possible to 
establish the graph of relative reaction rate shown in Figure 11. 
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Equation 4: Competitive Inhibition.  KM is the equilibrium constant, [S] is the SAH substrate 
concentration, [I] is the MT-DadMe inhibitor concentration, KI is the inhibition constant, v0 is the initial 
rate in the absence of the inhibitor, and v’0 is the initial rate in the presence of the inhibitor. 
 
 
Figure 11: Reaction Rates, “CSTR”-like conditions 
  
Sub-section 2 Microfluidic conditions 
The microfluidic environment differs from the “CSTR”-like environment in crucial 
aspects related to the flow conditions.  The microfluidic condition is under laminar 
constant flow conditions.  This is unlike a “CSTR”-like condition, where there is a well- 
mixed fixed volume with no net exchange.  Laminar flow conditions are marked by 
parallel fluid streamlines, with little chaotic mixing.  This means that fresh substrate 
arrives continuously, and product is removed.  The laminar flow conditions that present 
in the microfluidic channel (Reynolds number<<1) imply that only the substrate and 
inhibitor molecules in the flow streams near the electrode/chitosan boundary layer will 
interact, while the vast majority pass above the enzyme and do not interact at all.  This is 
shown (not to scale) in Figure 12 below. 
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This interaction volume can be estimated based on the thickness of the deposited 
chitosan hydrogel matrix.  Based on previous observations of dry chitosan measurements 
and the aqueous swell ratio, the electrodeposited chitosan is approximately 10-20µm 
thick.  The microchannel was fabricated to be 500µm wide and 150µm tall.  The gold 
electrode area is 0.5mm2; chitosan is assumed to fully cover the electrodeposition area.  
The enzyme is conjugated to the chitosan hydrogel in a random fashion, with exposed 
enzyme on the chitosan surface and accessible enzyme within the loose hydrogel bulk.  
The laminar flow restricts full mixing, so only flow streams that impinge directly on the 
chitosan thickness, or those within the boundary layer and near to it would interact with 
the conjugated enzyme.  Considering the low hydrogel density, and low Reynolds 
number flow conditions, the interaction height would be 20-40µm.  Therefore, it is 
estimated that only 13-26% of the total fluid volume above the electrode interacts with 
the conjugated enzyme. 
 
Figure 12: Interaction volume (not to scale) 
 
This analysis from inhibitor studies done in the “CSTR”-like conditions system can 
be compared with the data collected in the microfluidic chip (Figure 5).  It is possible to 
calculate the reaction rate in the microfluidic chip 
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Equation 5: Reaction rate in microfluidic chip 
 
Recalling the pfs reaction equation from Figure 1, the final [SRH] concentration can be 
written as 
 
Equation 6: Final SRH concentration, as a function of enzymatic conversion 
 
The flow through the system was fixed by syringe pump at 4µL/min, for 30min, to 
yield a sample volume of 120µL.  The average enzymatic conversion of SAH was taken 
from Figure 9, which can easily be shown to be equivalent to the relative reaction rate.  
Collecting this data together, the reaction rate can be tabulated as shown below: 






conversion of SAH == 
Relative Reaction Rate 
Final [SRH] Reaction Rate in 
Microfluidic Device 
125nM 103% 1.03mM 572.2nM/hr 
375nM 92.18% 0.922mM 512.1nM/hr 
500nM 69.52% 0.695mM 386.2nM/hr 
1000nM 19.86% 0.199mM 110.3nM/hr 
2500nM 
1mM 
2.43% 0.024mM 13.5nM/hr 
 
Sub-section 3 Comparison of “CSTR”-like calculations and Microfluidic 
Conditions 
It is now possible to compare the results from of pfs inhibition in a microfluidic 








Figure 13: Relative Reaction Rates: Microfluidic Chip vs. “CSTR”-like calculations 
 
Section 7 Conclusion 
 This demonstrates the design of a microfluidic chip for use in enzyme inhibitor 
analysis.  Chitosan-conjugated pfs enzyme was electrodeposited within the chip in a 
spatially localized process that maintained enzyme conversion activity.  The tight-binding 
substrate analogue inhibitor was used to demonstrate biochemical inhibition of pfs 
enzyme conversion activity.  Analysis of the inhibition response of the experimental 
microfluidic data shows a decaying reaction rate with increasing inhibitor concentration.  
This agrees well with calculations based on “CSTR”-like conditions, and demonstrates a 
classic case of biochemical inhibition, where higher concentrations of inhibitor retard the 
reaction.  This microfluidic chip can be used to screen other compounds for their efficacy 
as an inhibitor to the quorum-sensing pathway. 
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Chapter 3: Design Optimizations for EF-BioMEMs2 
Section 1 Introduction 
Enzyme-functionalized biological microfluidic systems (EF-BioMEMs) provide an 
attractive approach to understanding and modifying enzymatic pathways by separating 
and interrogating individual reaction steps at localized sites in a microfluidic network.  
Our group has previously shown that electrodeposited chitosan enables immobilization of 
an enzyme at a specific site while maintaining its catalytic activity [33][39].  While 
promising as a methodology to replicate metabolic pathways and search for inhibitors as 
drug candidates, these investigations also revealed unintended (or parasitic) effects, 
including products generated by the enzyme either (1) in the homogeneous phase (in the 
liquid), or (2) nonspecifically bound to microchannel surfaces.  Here, EF-BioMEMs 
designs are reported that significantly suppress these parasitic effects.  To reduce 
homogeneous reactions new packaging and assembly strategy have been developed that 
eliminates fluid reservoirs that are commonly used for fluidic interconnects with external 
tubing.  To suppress reactions by nonspecifically bound enzyme on microchannel walls a 
cross-flow microfluidic network design has been implemented so that enzyme flow for 
assembly and substrate/product for reaction share only the region where the enzyme is 
immobilized at the intended reaction site. 
 
Sub-section 1 Motivation: Reducing Unintended Enzyme Reactions 
The previous section demonstrated conversion activity from chitosan-conjugated 
enzyme assembled in a microfluidic device.  This is corroborated by other published 
                                                
2 Also published in Biomedical Microdevices [40]  
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studies from our group [39].  While these results showed clear enzyme activity at the 
assembled active sites, it was accompanied by notable (∼15-30%) background (or 
“parasitic”) reaction that occurred elsewhere in the microfluidic system 
(signal/background ratio, or S/B, =3-6X).  This is not surprising, given that the surface 
area and volume at the reaction site comprised only ~0.2% of the total wall area and 
volume of the microfluidic system.  The result indicates that the active site is >1000X 
more efficient than unintended (parasitic) sites in the microfluidic network.  These 
background signals appear in control experiments and are not associated with the 
intended catalytic action at the enzyme assembly sites.  Accordingly, background 
reaction channels are referred to as “parasitic” in that they produce reactions that add to 
and interfere with efforts to localize reactions at the electrode sites. 
The purpose of the present work is to reduce two significant parasitic reaction 
mechanisms in our EF-BioMEMs.  One is a homogeneous reaction mechanism, in that 
substrate and enzyme react while in the fluid phase.  It occurs because active enzyme is 
retained in reservoir areas where fluidic interconnects are made at the packaging level.  
The other is a heterogeneous reaction mechanism, in which enzyme nonspecifically 
bound to microfluidic channel walls reacts with substrate impinging from the fluid phase.  
These mechanisms are depicted schematically in Figure 1(d). 
 
Sub-section 2 Eliminating reservoir dead volume 
Connections between an EF-BioMEMs chip and external sources of fluids are 
essential to operate the chip.  However, alignment of fluidic inputs/outputs (I/O’s) to the 
microchannels can be challenging.  A conventional approach is to design a larger fluidic 
reservoir as an interface between on-chip microfluidic channels and external fluidic 
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connections at the packaging level, reducing the precision needed for alignment.  This 
approach has been used for tubing connection in microfluidics from individual 
microsystems [2][9][11][15] to large-scale integration [17][22][23].  The reservoirs are not readily 
flushed since their geometry leaves dead volume regions which entrap reactive 
biomolecules (e.g. enzymes) for extended periods of time, causing homogeneous 
parasitic reactions and altering the apparent conversion efficiency and time dependence 
of intended enzyme reaction steps [12][16]. 
To avoid the homogenous parasitic reactions in interconnect dead volume, a new 
packaging technique has been implemented that involves fabricating aligners on soft 
lithography molds to improve the alignment capability for interfacing between in-plane 
microfluidic channels and external tubing.  The macro-scale packaging and assembly 
technology issues and their effect on microfluidic performance have been reviewed in 
literature [7].  Our design eliminates the interconnect reservoirs by fabricating on-chip 
SU-8 aligner plugs, analogous to Si plugs made by DRIE [8], to guide microfluidic 
packaging connections.  The relevant properties of PDMS that enable this technique are 
given elsewhere [17].  Here, PDMS sealing around tubing 20% larger than the nominal 
diameter of the hole is shown that builds on the demonstration in the literature [3].  Two 
rigid Plexiglas plates are employed to clamp the PDMS-glass chip, and stabilize the pogo 
pins on their electrode contacts, similar to the demonstration by Bhagat et al. where rigid 
clamps were employed to mechanically stabilize the tubing [1].  Background biochemical 
activity is reduced by 33% in the new design. 
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Sub-section 3 Reducing impact of nonspecifically bound enzyme  
The presence of microfluidic channel walls with area far in excess of that of the 
intended enzyme reaction site is intrinsic to the geometry of EF-BioMEMs.  As indicated 
in Figure 1(d), however, our EF-BioMEMs design employed a single channel to (1) first 
activate the enzyme to react with chitosan, and then deliver the enzyme-chitosan 
conjugate to be immobilized on the assembly site by electrical signal, and (2) 
subsequently to transport substrate to the active site and product away from it to a 
downstream collection point.  This configuration exposed substrate to nonspecifically 
bound enzyme through the full length of the channel prior to its collection. 
To reduce the contribution of enzyme nonspecifically bound on channel walls, a 
cross-flow EF-BioMEMs channel design is implemented.  The channel that carries the 
enzyme-chitosan conjugate for immobilization is orthogonal to a second channel that 
carries substrate and product downstream to an exhaust location for analysis of enzyme 
conversion rate.  Thus, substrate is exposed to enzyme only at the active site, suppressing 
the contribution of nonspecifically bound enzyme to measured conversion rates. 
This experimental strategy utilizing cross-flow microchannels to separate flow 
directions for sequential biochemical reactions has been broadly used in DNA/protein 
separation [15], droplet formation [21] and enzymatic reaction [2], where the cross area is the 
focus point for sample manipulation or for reagent introduction.  In this work, the 
metabolic enzyme pfs is spatially assembled at the intersection between two flow 
channels so that the flow direction for enzyme assembly is separated from the subsequent 
flow direction for enzymatic reaction.  This design enhancement is an important advance 
toward our goal of reconstructing multiple metabolic pathway enzymes.  Spatially 
separating individual reaction steps in microfluidics allows for an understanding of 
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reaction details and testing of molecules that can modify pathways and kinetics.  In drug 
discovery, for example, a molecular species that inhibits a bacterial signaling pathway 
enzyme can be a candidate for an antimicrobial drug whose action is to interfere with cell 
signaling or quorum sensing (more on this in Section Chapter 2:).  By using a cross-flow 
design to separate flow directions, the non-specific heterogeneous reactions on 
microchannel walls are significantly suppressed and reduce the background signal by an 
additional 50%.  Together, these EF-BioMEMs design modifications result in a combined 
enhancement of 3.38X in the signal/background ratio (from 0.72 to 2.43). 
 
Section 2 Optimized Microfluidic Chip Design and Fabrication 
For this work, a soft lithography molding approach was employed [17] to the 
fabrication of the EF-BioMEMs, in contrast to our previous work on enzyme reactions in 
BioMEMs, which incorporated SU8 sidewalls [16].  This accelerates development and 
testing of the concept, while removes some of the benefits of our earlier design [18]. 
 
Sub-section 1 Packaging aligners to eliminate interconnect reservoirs 
To avoid homogeneous parasitic reaction in interconnect dead volume, minimal or no 
interconnect reservoir is desired.  To achieve this goal, packaging aligners using a soft 
lithography molding process were designed and fabricated.  As shown in Figure 14(a), 
packaging aligners of 500µm in diameter were patterned from a 200µm-thick SU-8 layer 
on the top of the 150µm-thick SU-8 mold layer used to define the 500µm-wide 
microchannels.  A design offset of 1.07% was applied in the photomask to accommodate 





Figure 14: Eliminating interconnect 
reservoirs by aligners on prototype mold to 
guide microfluidic packaging.  (a) Aligners 
on prototype mold.  (b) Packaging way #1: 
punch holes via PDMS followed by coupler 
insertion.  (c) Packaging way #2: punch 
holes via PDMS followed by tubing 
insertion.  (d) Packaging way #3: align 
couplers for PDMS curing followed by 
coupler removal and tubing insertion 
 
Three ways of PDMS curing and packaging have been explored to assemble the final 
chip without interconnect reservoirs to external tubing.  In Figure 14(b), a sharpened 
coupler (fabricated in-house from a 25ga coupler, 0.020” OD) was used to punch through 
the 3mm-thick PDMS layer along the pits formed by the packaging aligners during the 
PDMS curing process.  Holes for electrical contact (0.1” diameter) were also punched in 
the PDMS before the microchannel side was wetted with methanol and bonded to a glass 
slide (1”x3”).  The whole chip was then sandwiched with screws between two Plexiglas 
clamp plates, and with pogo pins inserted through holes in the top plate for electrical 
connection.  Finally, flat-end couplers of the same size were inserted into the punched 
holes and connected to external PE tubing (0.015” ID).  
Figure 14 (c) shows the same strategy as Figure 14 (b) except that the external tubing 
was directly inserted into the punched holes in PDMS.  In Figure 14 (d), couplers with 
inner-diameter of 0.024” (20ga, 0.036” OD) were gently placed onto the aligners of 
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0.5mm OD and stabilized with a Plexiglas coupling holder while the PDMS cured.  Then 
the couplers were removed and external Microbore PTFE tubing (0.022” ID, 0.042” OD) 
was inserted into the well-defined connection holes (0.036” OD).  Due to capillary action, 
couplers were normally filled with PDMS after curing, which was advantageous because 
it allowed a slug of PDMS to be removed, facilitating better sealing.  A packaged chip 
following the procedure of Figure 14 (d) is shown in Figure 15(b) with blue dye flowing 
through the cross channel. 
Finally, leak testing showed that all three strategies provide leak-tight sealing.  The 
designs in Figure 14 (b) and (c) were predominantly used in our experiments since they 
minimized the dead volume between the coupler and tubing as well. 
 
Sub-section 2 Cross-channel design to separate sequential flow directions 
Cross channels (500µm-wide, 150µm-high) as shown in Figure 15 (b) were designed 
to separate the sequential flow direction of enzyme assembly (AC) from the flow 
direction of the subsequent enzymatic reaction (BD).  No on-chip valves were included 
for this test-of-concept design.  Parafilm was used to seal the connecting couplers/tubing 
that were not being used for a given experiment step to minimize the flow into these 
channels.  After enzyme assembly, PBS buffer was pumped into the top three ports of the 
chip in Figure 15 (b) to rinse the channels.  In the following experiment, substrate was 
continuously pumped through the reaction site at the intersection for ~ 10 hours.  The 
serpentine channel connecting the bottom port was included to increase channel length in 
an efficient manner to prevent any enzyme from defusing back to the reaction site.  The 




Figure 15: Device and packaging.  (a) Fabricated aligners on prototype mold.  (b) Blue dye solution 
occupying a leak-tight cross-channel device.  PE tubing was inserted.  In experiment, enzyme solution 
for post-fabricated assembly flowed AC, and substrate solution (SAH) subsequently flowed BD. 
 
Section 3 Experimental methods 
This section describes the methods employed to functionalize the microfluidic device 
with active pfs enzyme. 
Sub-section 1 Enzyme assembly and enzymatic reactions 
After leak testing of the assembled microfluidic chip, the microchannel and all the 
connecting tubing were rinsed with DI water at 50µL/min flow rate for 30 minutes.  
Then, Bovine Serum Albumin (BSA) solution (1 % (w/v) in PBS buffer) was pumped 
into the microchannel at 3µL/min flow rate for 2 hours to block non-specific binding.  
After PBS buffer rinsing for 15min at 5 µL/min flow rate, pfs-chitosan conjugate solution 
was pumped at the same flow rate until the microchannel was completely filled before the 
pump was stopped.  For all the control experiments to test the background signals, no 
electrical signal was applied to the working electrode during incubation of 240 seconds, 
as shown in Figure 17.  The pfs-chitosan conjugate solution was then drained from the 
system, and the electrodeposited pfs-chitosan conjugate was washed with PBS buffer at 
5µL/min flow rate for 30 min.  Next, enzymatic reactions were performed by 
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continuously pumping the SAH substrate solution (1mM SAH in 50mM sodium 
phosphate buffer, pH 7.2) for 2hr at 0.4, 1 and 4µL/min flow rates by a Genie Plus 
syringe pump.  During the second hour at each flow rate, samples were collected every 
20 min.  They were then extracted with chloroform and stored at -20oC before analyzing 
via HPLC. 
For the experiments to test the overall conversion by site-specifically assembled 
enzyme and non-specifically assembled enzyme, an electrical signal of constant current 
density 3 A/m2 was applied to maintain negative bias voltage on the working electrode 
for 240 seconds, while a second electrode served as the counter electrode.  All other steps 
followed the same aforementioned procedure. 
 
Section 4 Results 
Sub-section 1 Quantification and simulation of interconnect dead volume 
To better understand the degree to which interconnect dead volume affects the 
system response at a specific reaction site, the changes in fluorescent dye intensity in the 
microchannel under flow were measured and quantified, at a point 8.75 mm downstream 
of the interconnect point over the active electrode (Figure 16(a)).  The interconnect 
reservoir is 2 mm in diameter and 0.15 mm high, and the microchannel is 0.5 mm wide.  
The upstream external tubing was first filled with dye solution (Cy5) before inserting into 
the PDMS chip.  A syringe pump pumped the dye solution into the microchannel at 
1µL/min flow rate, and a fluorescent microscope simultaneously recorded the dye 
intensity over the electrode.  The microscope images were converted into grayscale 
images and processed by ImageJ software (National Institutes of Health).  As a 
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comparison, quantification was also performed for a microchannel of the same dimension 
without the interconnect reservoir (Figure 16 (b)). 
Figure 16 (c) shows the changes in relative intensity over the electrode for a 
microchannel with interconnect reservoirs (pink solid line), and for a microchannel 
without interconnect reservoirs (blue dashed line).  The left portion of the curves shows 
that it takes about 50 sec for the dye solution to reach the electrode.  The right portion of 
the curves shows that in the microchannel with the interconnect reservoir, the dye 
intensity increases from 10% to 90% in 61 sec, while in the microchannel without 
interconnect reservoir it only takes 32 sec.  The intensity difference over time in the 
microchannels with and without reservoir (Figure 16 (e), blue line) differs for more than 
100 sec before it plateaus at the maximum value of 0.32. 
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Figure 16: The residence time distribution for channels with, and without, reservoirs.  Dye solution was 
monitored over electrode patches 12mm downstream the microchannels.  (a) With reservoir.  Dye intensity 
increasing from 10% to 90% takes 61 sec in experiment and 75 sec in simulation.  (b) Without reservoir.  
Dye intensity increasing from 10% to 90% takes 32 sec in experiment and 25 sec in simulation.  (c) The 
simulated difference of intensity change from the interconnect configuration with, and without, reservoir.  
 
Finite element simulation was also performed to investigate the effects of the 
interconnect reservoir on the system response at the same location as in the experimental 
quantification.  This simulation was performed using COMSOL Multi-Physics by 
modeling the switching of the incoming flow to dye solution at the interconnection point, 
and by integrating the dye intensity over the electrode.  The left portion of the simulation 
curves (Figure 16 (d)) shows that it also takes about 35 sec for the dye solution to reach 
the electrode.  The longer response time in this portion of the experiments is probably due 
the lag associated with pump startup and the extra tubing connecting the syringe pump.  
The right portion of the simulation curves shows that for a microchannel with an 
interconnect reservoir, it takes 75 sec for the dye intensity to increase from 10% to 90% 
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(Figure 16 (d), solid pink line), while for a microchannel without an interconnect 
reservoir it only takes 25 sec (Figure 16 (d), dashed blue line).  The pink open line in 
Figure 16 (e) is the intensity difference in the microchannels with and without reservoir 
over time, which shows that the intensity over this specific electrode site differs for more 
than 100 sec before it reaches plateau with the maximum value 0.30.  The shorter time to 
reach plateau for the microchannel with reservoir in the experiments is probably because 
of the pump.  The flow driven by our syringe pump is not strictly continuous, but 
advances in a step-wise manner that is disadvantageous in applications where smooth 
continuous flow is desired. 
Together, both the experimental quantification and the finite element simulation 
confirm that the system response (as measured downstream at the reaction site) has 
improved 2-3X by eliminating the dead volume in interconnect reservoirs, therefore 
avoiding the homogenous parasitic reactions in the dead volume. 
 
Sub-section 2 Quantification of parasitic reactions and overall analysis 
Part 1 Enzyme reaction and controls 
To determine the benefit of the design changes detailed above which focus on 
microfluidics, enzymatic conversions in these various designs were compared to test the 
effects of parasitic reactions.  This is schematically indicated in Figure 17 for the cases of 
(1) single channel with interconnect reservoirs, (2) single channel without interconnect 
reservoirs and (3) cross channel without reservoirs.  The microchannels were first filled 
with pfs enzyme solution, and then incubated in the enzyme solution in a static state for 
4min without applying an electrical signal to the assembly site (no electrodeposition).  
Next, enzyme solution was drained from the microchannel, and buffer solution was 
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introduced to rinse the channel.  Finally, enzymatic substrate SAH was introduced, and 
the downstream solution was collected for analysis by HPLC. 
 
Figure 17: Minimization of parasitic reactions.  To test the background signal by non-specifically bound 
enzyme, pfs enzyme solution was introduced without electro-assembly followed by buffer rinsing, then 
enzymatic substrate SAH was introduced and collected downstream to be analyzed by HPLC.  (a)  (b) 
Eliminating dead volume in interconnect reservoir and thereby eliminating homogeneous reactions).  (b)  
(c) Eliminating non-specific binding of enzyme to channel walls and thereby minimizing heterogeneous 
reactions.   
 
The experimental results in Figure 18 show that in the case of the single channel with 
reservoirs, the conversion of SAH into SRH and adenine was 44.5 ± 2.9%, 19.3 ± 0.4% 
and 5.0 ± 0.3% at 0.4µL/min, 1µL/min and 4µL/min flow rates, respectively.  In the case 
of single channel without reservoirs, the conversion was 29.7 ± 1.8%, 13.4 ± 0.7% and 
4.1 ± 0.3% at 0.4µL/min, 1µL/min and 4µL/min flow rates, respectively.  In the case of 
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cross channel without reservoirs, the conversion was 13.3 ± 0.2%, 6.8 ± 0.3% and 1.5 ± 
0.2% at 0.4µL/min, 1µL/min and 4µL/min flow rates, respectively. 
 
Figure 18: Background signals (parasitic enzymatic conversion) at different flow rates.  pfs enzyme 
solution was introduced without electro-assembly followed by buffer rinsing, then enzymatic substrate 
SAH was introduced and collected downstream to be analyzed by HPLC.  Legend: 1-ch_w/ res.: single 
channel with interconnect reservoirs (blue); 1-ch_No res.: single channel without interconnect reservoirs 
(purple); X-ch_No res: cross-channel without interconnect reservoirs (red).   
 
Combined, these results demonstrate that by eliminating the reservoirs, the 
background signal from homogeneous parasitic reactions in the dead volume of 
interconnects decreases by 33%.  By separating the flow directions with the cross channel 
configuration, the background signals from heterogeneous parasitic reactions on the 
microchannel walls further decreases by 63%.  The total decrease of background signal 
from the configuration of Figure 17 (a) to that of Figure 17 (c) is 65~70% for the three 
flow rates tested. 
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Part 2 Enzyme conversion signal/background 
To better understand the improvements realized by eliminating interconnect dead 
volume and separating the flow directions for sequential enzymatic reactions, site-
specific heterogeneous enzymatic reactions on the assembly electrode were also 
performed side by side to compare with the control experiments.  The experiments differ 
from the control experiments only in that an electrical signal of 3A/m2 current density 
was applied to electrodeposit pfs-chitosan conjugate onto the assembly electrodes during 
the 4-min incubation of enzyme solution in the channels.  The experiments were 
performed at 0.4µL/min flow rate for all the three configurations shown in Figure 17.  
The enzyme solution for all the experiments and controls was from the same batch, while 
the conjugate solution was made right before experiments.  The background signal was 
taken from Figure 18 at the flow rate of 0.4µL/min. 
The experiment results in Figure 19 show that in the case of the single channel with 
reservoirs, the site-specific conversion is 32.0 ± 1.6% and the background signal is as 
high as 44.5 ± 2.9% yielding a signal/background (S/B) ratio of 0.72.  In the case of the 
single channel without reservoirs design, the site-specific conversion is 38.1 ± 0.6% 
while the background signal is 29.7 ± 1.8% with the S/B ratio of 1.28.  In the case of the 
cross channel without reservoirs design, the site-specific conversion is 32.3 ± 3.5% while 
the background signal is as low as 13.4 ± 0.7% with the S/B ratio of 2.43.  The 
crosshatched area in Figure 19 (X-ch_No res) represents calculated missing reaction 
correction due to a slight reduction in electrode area upon alignment of intersection 
channels onto electrode.  Note, however, the electrode with only 0.75mm2 area represents 
only 1% of the total microchannel surface (77.15mm2), and the volume above the 
electrode site (0.11µL) represents only 2.5% of the total microenvironment volume 
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(4.45µL).  Therefore, the conversion on the enzyme-activated electrode is more than two 
orders of magnitude faster per unit area than the background signal resulting from either 
parasitic mechanism. 
 
Figure 19: Total conversions in devices with electrodeposited pfs.  Conversion by non-specifically bound 
enzymes is in blue, and conversion by site-specifically assembled enzymes is in red.  For the non-specific 
conversion, no electrical signal was applied (no pfs-chitosan conjugate deposited).  For the total conversion, 
an electrical signal of 3A/m2 current density was applied for 4min (pfs-chitosan conjugate assembled onto 
0.75 mm2 sites).  Enzymatic reaction was performed at 0.4µL/min flow rate. 
 
In summary, these results demonstrate that by utilizing our packaging and 
experimental strategies to minimize the parasitic reactions in interconnect dead volume 
and by non-specific binding on microchannel walls, the signal-to-background ratio of 
sequential enzymatic reactions was improved from 0.72 to 2.43. 
 
Section 5 Discussion 
Estimation of enzyme specific activity was reported previously [16].  The enzyme 
specific activity for the pfs-chitosan conjugate assembled on the electrode in this paper 
(0.35 µmol SAH/ min/ mg pfs) is lower than what was estimated in the previous 
publication (3.7 µmol SAH/ min/ mg pfs).  The difference might be due to several 
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reasons.  First, the enzyme solution used here was from a different batch prepared at 
different time that might have different specific activity.  Second, the EF-BioMEMs chip 
used here has a different configuration that might result in different activity after enzyme 
assembly.  The chip design in Figure 15 consists of two counter electrodes besides the 
working electrode for enzyme assembly.  During electrodeposition, this configuration 
might generate higher pH gradient at the working electrode surface, thereby deactivating 
the enzyme activity.  Nonetheless, the estimated specific activity is within the range of 
reported pfs specific activities in the literature that vary over three orders of magnitude 
[4][6][20].  Importantly, given the enzyme specific activity and flow rate conditions, the 
purpose of suppressing parasitic reactions has been demonstrated by the decreasing 
background signal and increasing S/B ratio, as shown in Figure 18 and Figure 19, while 
the site-specific conversions remained at the same level. 
The use of chitosan as an intermediary interface allows for the programmable 
assembly of enzymes in a microfluidic network, making this EF-BioMEMs platform both 
versatile and functional [5][24].  By improving the ability to specify the site of the 
individual enzymatic reactions, these modifications allow for the construction of the 
complex networks needed to simulate biologically relevant pathways.  In these networks, 
each enzymatic step would be catalyzing a specific reaction with known conversion 
efficiency.  The conversation rate of each step could be measured independently, and the 
conversion action would be attributable only the specifically bound enzyme, with 
minimal side-reactions. 
Advanced methods for reducing parasitic reactions can be further developed.  
Homogenous parasitic reactions could be addressed by the use of low dead-volume 
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interconnect designs to interface the microfluidic channel with the external pumping and 
fluid delivery.  By incorporating in-line valves for flow control, it is possible to envision 
purging flows which would flush the channel areas of any non-specifically bound 
enzyme.  Additionally, through stronger and longer chemical pretreatment of the 
microchannel walls than the BSA solution used here, it might be possible to further repel 
enzyme bounding and thereby eliminate heterogeneous parasitic reactions. 
 
Section 6 Conclusion 
In summary, this work demonstrates a novel packaging technique to minimize the 
homogeneous parasitic reactions in the dead volume of packaging interconnects and an 
experimental strategy to minimize heterogeneous parasitic reactions due to non-specific 
binding on microchannel walls.  Our experiment and simulation results prove that the 
combined strategies of fabricating packaging aligners to avoid the interconnect reservoirs 
and separating flow directions for enzyme immobilization and the subsequent enzymatic 
reactions are efficient in minimizing the background noise up to 70%.  These strategies 
increase the signal-to-background ratio from 0.72 to 2.43 for the given chip design and 
enzyme activity.  These techniques can be easily applied to versatile microfluidic chips to 
minimize cross-contamination in sequential biochemical reactions. 
 
Chapter 4: Materials & Methods 
Section 1 Chemicals and Materials 
 The materials used were similar to those used in previous works [38][39][40].  These 
materials were stored in the Payne, Bentley, and Rubloff laboratories at University of 
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Maryland, College Park, and the FabLab facilities in the Maryland Nanocenter.  These 
materials are listed in Table 4 below: 
Table 4: Chemicals and Materials List 
Material Application Source 
Silicon wafers Substrates for SU8 processing University Wafer 
Gold Microchannel electrode material Kurt Lesker 
Chromium Adhesion layer to allow for gold electrode 
application to glass substrate 
Kurt Lesker 
Polydimethylsiloxane 
(PDMS), aka Sylgard 184 
Construction material for microchannel Robert McKweon 
Microbore PTFE tubing, 
0.022”(0.56mm) ID 
Compatible tubing to connect microchannels 
to pumps and pressure supply 
Cole Parmer, P/N  
HW-06417-21 
PE tubing Biochemical liquid handling Instech Laboratories 
Steel couplers (25ga, 20ga) Novel interconnect fabrication Instech Laboratories 
Single-Use syringes/ 
BD Needle Combinations 
Biochemical liquid handling VWR 
Microcentrifuge tubes Biochemical liquid storage VWR 
Plain glass microslides Substrate for the microchannel VWR 
Syringe Pump Controlled delivery of fluid to microfluidic 
chip 
Kent Scientific, Genie Plus 
Infusion/Withdrawal Pump 
Acetone/Methanol/IPA Wafer cleaning solvents Fisher Chemical 
SU8-50 photoresist Construction material for valve mold MicroChem 
SU8 Developer Developer for SU8-50 photoresist MicroChem 
Shipley 1813 Photoresist Gold & Chromium Photoresist MicroChem 
Shipley 352 Developer Developing agent for Shipley 1813 Photoresist MicroChem 
Transene TFA etchant Gold etchant solution MicroChem 
Transene 1020 Chromium etchant solution MicroChem 
Luria Broth E. coli culture medium Becton Dickinson 
Ampicillin E. coli culture medium Fisher Chemical 
Sodium Chloride  E. coli culture medium Fisher Chemical 
isopropyl b-D-thiogalacto-
pyranoside (IPTG) 
Enzyme purification Sigma Aldrich 
Imidazole Enzyme purification Sigma Aldrich 
Bleach Disinfectant James Austin Co. 
Sodium cyanoborohydride Stabilize pfs-chitosan binding Sigma Aldrich 
Tyrosinase 
(from mushroom) 
Manufacturer reported activity: 1,530 
units/mg solid; formation of tyrosine tag for 
enzyme conjugation to chitosan 
Sigma Aldrich 
BSA Bovine Serum Albumin, to block non-specific 
chitosan binding to microchannel 
Sigma Aldrich 
Chitosan Minimum 85 % deacetylated chitin; molecular 
weight 200,000 g/mol, from crab shells 
Sigma Aldrich 
SAH S-adenosylhomocysteine, pfs substrate Sigma Aldrich 
Non-fat dry milk To discourage non-specific chitosan bonding, 
and stabilize pH near optimum value. 
BioRad 
Hydrochloric Acid Hydrochloric Acid, for channel cleaning J.T. Baker 
Phosphate Buffered Saline 
(PBS) 
(2.7mM KCl, 137mM NaCl, 
1.5mM KH2PO4, 8.1mM 
Na2HPO4, pH 7.5) 
Buffer solution to flush out chitosan conjugate 
without causing premature precipitation, and 
stabilize the electrodeposited chitosan. 




ddH2O Doubly deionized water, for channel rinsing 
Autoclaved before use 
Made in-house 
Chloroform Sample stabilization Fisher Chemical 
DI Water (HPLC grade) HPLC solvent component Fisher Chemical 
Acetonitrile (HPLC grade) HPLC solvent component Fisher Chemical 
 
Section 2 Methods of Preparation 
Sub-section 1 Plasmid construction 
pTrcHis-pfs-Tyr plasmid construction has been reported elsewhere [5].  Briefly, the 
plasmid was constructed by PCR amplification of pfs from E. coli wild type strain 
W3110.  Following digestion, the PCR products were extracted by gel purification and 
inserted into pTrcHisC (Invitrogen).  DNA sequencing was performed to verify construct 
integrity.  The plasmid was transformed into E. coli DH5α (defective LuxS strain). 
Sub-section 2 Purification of (His)6-pfs-(Tyr)5  
The procedure for preparation of purified (His)6-pfs-(Tyr)5 has been covered 
elsewhere [5], but is included here for completeness.  E. coli DH5α containing pTrcHis-
pfs-Tyr was cultured at 37ºC and 250 rpm in LB medium supplemented with ampicillin at 
50µg/mL concentration.  When the OD600nm reached 0.5-0.6, IPTG was added to induce 
enzyme production at a final concentration of 1mM IPTG.  After an additional 5 hr, the 
culture was centrifuged for 10min at 10,000g’s, and the cell pellet stored at -20ºC.  The 
thawed pellet was re-suspended in PBS + 10mM imidazole, pH 7.5, placed in an ice-
water bath, and the cells lysed by sonication (Fisher Scientific Sonic Dismembrator 550).  
The lysed cells were centrifuged for 10min at 16,000g to remove insoluble cell debris, 
and the supernatant filtered though 0.22µm PES filter.  The enzyme was purified from the 
filtered soluble cell extract by immobilized metal-ion affinity chromatography (IMAC) 
using a 5mL HisTrap chelating column (Amersham Biosciences).  Prior to loading the 
filtered extract, the column was charged with Ni2+ions using 0.1M NiSO4, washed with 
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deionized water, and equilibrated with 3 column volumes (CVs) of 20mM sodium 
phosphate, 250mM NaCl, 10mM imidazole, pH 7.4.  After loading the filtered extract, 
the column was washed with 3 CVs of the previous buffer, washed again with 3 CVs of 
20mM sodium phosphate, 250mM NaCl, 50mM imidazole, pH 7.4, and the protein was 
eluted using 1.5 CVs of 20mM sodium phosphate, 250mM NaCl, 350mM imidazole, pH 
7.4.  All steps were performed at 2mL/min (1cm/min linear velocity).  The eluted sample 
was dialyzed overnight (16hr) at 4ºC into PBS.  Purified protein concentration was 
determined by UV/vis spectrophotometery (DU 640, Beckman, Fullerton, CA) using UV 
light at 280nm wavelength.  The protein solution was mixed 2:1 with glycerol, aliquoted 
and stored at -80ºC. 
 
Sub-section 3 pfs-chitosan conjugate preparation 
Chitosan, enzyme pfs, and pfs-chitosan conjugate preparation procedures were 
reported elsewhere [14][16].  Briefly, Chitosan solution was prepared by dissolving chitosan 
flakes in HCl solution at pH ~ 2 overnight, then the pH was adjusted to pH 4.8 by adding 
1 M NaOH dropwise before being filtered and stored at 4ºC.  Plasmid pTrcHis-pfs-Tyr 
was first constructed by PCR amplification of pfs from E. coli wild type strain W3110.  
Following digestion, the PCR products were extracted by gel purification and inserted 
into pTrcHisC (Invitrogen).  DNA sequencing was performed to verify construct 
integrity.  The plasmid was transformed into E. coli DH5a (defective luxS strain).  E. coli 
DH5α containing pTrcHis-pfs-Tyr was cultured and enzyme production was induced 
before the cells were lysed by sonication.  Next, the enzyme was purified by ion-metal 
affinity chromatography (IMAC) before being mixed 2:1 with glycerol, divided into 
aliquots, and stored at -80oC.  The conjugate was prepared by incubating enzyme pfs, 
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tyrosinase, and chitosan in sodium phosphate buffer for 2hr at room temperature followed 
by incubation in sodium cyanoborohydride for 30min to stabilize pfs-chitosan binding. 
 
Section 3 Analysis of enzymatic reaction products  
A Waters Spherisorb Silica column (250 × 4.6mm) with 5mm beads (80 Å pore) was 
used in reversed-phase mode with 5mL sample injection size and a mobile phase of 70:30 
acetonitrile: water at 0.5mL/min.  Only HPLC-grade chemicals were used for the mobile 
phase.  The HPLC system consisted of two Dynamax model SD-200 pumps (with 10mL 
pump heads and mixing valve) and a Dynamax Absorbance Detector model UV-D II, and 
data was analyzed using Star 5.5 Chromatography Software (Rainin).  Conversion was 
calculated from elution data at 210nm absorbance. 
 
Chapter 5: Discussion 
Section 1 Summary of Key Findings 
This thesis work demonstrates the biochemical inhibition of the pfs enzyme in a 
microfluidic device.  Pfs is the first enzyme conversion step in the metabolic pathway 
used by bacteria during quorum sensing, so this achievement demonstrates a method to 
disrupt bacterial communication.  The pfs enzyme was spatially assembled at a defined 
site within an enzyme-functionalized microfluidic system and controllably exposed to 
varying concentrations of a substrate analog inhibitor, MT-DadMe-Immucillin-A.  The 
result was a decrease in enzyme conversion activity in a manner comparable to that 
observed in larger-scale well-mixed experimental configurations.  This demonstrates that 
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the EF-BioMEM system can be used to screen other compounds for the potential as 
enzyme inhibitors of the quorum-sensing pathway. 
This thesis work also describes design improvements that were implemented to 
reduce unintended enzyme reactions within the microfluidic device, and thus improves 
the overall system performance by increasing the signal-to-background ratio.  Unintended 
reactions were found to occur because of conversion activity from enzyme trapped within 
the dead volume of the device, and enzyme non-specifically bound to the sidewalls of the 
microchannel.  By implementing a novel packaging scheme, it was possible to eliminate 
the interconnect reservoir and reduce the background signal from homogenous reactions 
in the dead volume by 33%.  A cross-channel geometry was designed which separated 
the flow paths of the enzyme during functionalized, from the substrate during conversion.  
This change in geometry reduced the background signals from unintended heterogeneous 
reactions on the microchannel walls by an additional 63%.  Together, these strategies 
increased the signal-to-background ratio from 0.72 to 2.43 for the chip design presented. 
 
Section 2 Future Work 
Now that is has been demonstrated that enzyme inhibition can be observed in this 
design of microfluidic device, it would be desirable to use it to screen other compounds 
for their efficacy as pfs inhibitors.  Schramm’s research has identified listed several other 
picomolar and femtomolar pfs inhibitors [34][45][46][47][48] which could be candidates for 
future study. 
The Rubloff group at University of Maryland has done work to integrate on-chip 
pressure valves into the microfluidic network.  These valves are modeled after those 
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described by Quake and Melin [49].  By employing these valves and the cross-channel 
geometry described in Section Chapter 3:Section 2Sub-section 2, it is possible to design a 
microfluidic network that separates the flow directions of the enzyme, the substrate, and 
the substrate/inhibitor mixture so that higher throughput screening operations are 
possible. 
The issue of limited interaction between the flow stream and the assembled enzyme is 
addressed in Figure 12.  It would be desirable to position the enzyme in a way that would 
maximize its interaction with the substrate to increase the amount of conversion.  The 
Rubloff group has done work that involves fabricating a vertical chitosan membrane 
inside the microfluidic channel so that it is perpendicular to fluid flow.  This membrane 
can be further functionalized with active enzyme.  This geometrical rearrangement has 
been shown (unpublished work) to increase enzyme conversion, and would improve the 
signal response in subsequent inhibitor screening studies. 
 
Chapter 6: Appendix 
Section 1 Cost Analysis 
One intended application of a biofunctionalized microfluidic chip would be as a 
cartridge in applications unit for biochemical analysis.  To evaluate the feasibility of mass 
production of these microfluidic chips, a basic manufacturing cost analysis is presented in 
Table 5.  Each microchip costs $7.74/chip, and would require $3.71 worth of chemicals 
(not including enzyme) to biofunctionalized.  The typical processing time took 2 days, 
was done in the FabLab facility at the Maryland NanoCenter by a single worker. 
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Table 5: Manufacturing Cost Analysis 
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